Blocking Leptin Action One Week After Weaning Reverts most of the Programming Caused by Neonatal Hyperleptinemia in the Adult Rat

Abstract

Hyperleptinemia during lactation programs for higher serum leptin in 30-day-old and adult rats, associated with metabolic changes. Here we evaluated the inhibition of serum leptin at 29 and 30 days on the metabolic phenotype of rats programmed with leptin during lactation. Pups from Wistar rats were saline-injected or leptin-injected from postnatal day 1 to day 10. At 29 and 30 days old, animals were injected with anti-leptin antibody (LA and CA) or saline (LS and CS). In adult animals, higher visceral (+53%) and total fat mass (+33%), hyperleptinemia (+67%), hypertriglyceridemia (+47%), and hypoadiponectinemia (−44%) observed in LS group compared to CS were prevented by immunoneutralization of leptin, since LA group had those parameters values similar to CS group. However, immunoblockade of leptin in normal animals led to the same metabolic changes seen in leptin-treated animals, in addition to lower serum adiponectin (−77% vs. CS) and higher insulin resistance index (+37%). Liver sirtuin1 (SIRT1) was higher (+41%) only in LA group, suggesting a role for SIRT1 in the prevention of leptin programming. Hypothalamic OBR was lower and SOCS3 higher in LS group and these changes were normalized in LA group. In conclusion, blocking leptin action one week after weaning seems to revert most of the alterations observed in rats programmed by neonatal hyperleptinemia. Higher liver SIRT1 expression may be one of the mechanisms involved, leading to a better glucose and lipid metabolism. Our data suggest that the lack or the excess of leptin programs an adverse metabolic phenotype in adulthood.

Key words

leptin antibody - lactation - programming - hyperleptinemia

References

• 1 Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth.  Diabetology. 1993;  36 62-67
• 2 Moura EG, Passos MCF. Neonatal Programming of Body Weight Regulation and Energetic Metabolism.  Biosci Rep. 2005;  25 251-269
• 3 Moura EG, Lisboa PC, Passos MCF. Neonatal Programming of Neuroimmunomodulation – Role of Adipocytokines and Neuropeptides.  Neuroimmunomodulation. 2008;  15 176-188
• 4 Gluckman PD. Evolving a definition of disease.  Arch Dis Child. 2007;  92 1053-1054
• 5 Teixeira CV, Passos MCF, Ramos CF, Dutra S, Moura E. Leptin serum concentration in rats whose mothers were submitted to malnutrition during lactation.  J Nutr Biochem. 2002;  13 493-498
• 6 Lisboa PC, Passos MC, Dutra SC, Bonomo IT, Denolato AT, Reis AM, Moura EG. Leptin and prolactin, but not corticosterone, modulate body weight and thyroid function in protein-malnourished lactating rats.  Horm Metab Res. 2006;  38 295-299
• 7 Bonomo IT, Lisboa PC, Passos MC, Pazos-Moura CC, Reis AM, Moura EG. Prolactin inhibition in lactating rats changes leptin transfer through the milk.  Horm Metab Res. 2005;  37 220-225
• 8 Rodrigues AL, de Moura EG, Passos MC, Dutra SC, Lisboa PC. Postnatal early overnutrition changes the leptin signalling pathway in the hypothalamic-pituitary-thyroid axis of young and adult rats.  J Physiol. 2009;  587 2647-2661
• 9 de Oliveira Cravo C, Teixeira CV, Passos MC, Dutra SC, de Moura EG, Ramos C. Leptin treatment during the neonatal period is associated with higher food intake and adult body weight in rats.  Horm Metab Res. 2002;  34 400-405
• 10 Lins MC, de Moura EG, Lisboa PC, Bonomo IT, Passos MC. Effects of maternal leptin treatment during lactation on the body weight and leptin resistance of adult offspring.  Regul Pept. 2005;  127 197-202
• 11 Yura S, Itoh H, Sagawa N, Yamamoto H, Masuzaki H, Nakao K, Kawamura M, Takemura M, Kakui K, Ogawa Y, Fujii S. Role of premature leptin surge in obesity resulting from intrauterine undernutrition.  Cell Metab. 2005;  6 371-378
• 12 McMillen IC, Edwards LJ, Duffield J, Muhlhausler BS. Regulation of leptin synthesis and secretion before birth: implications for the early programming of adult obesity.  Reproduction. 2006;  131 415-427
• 13 Vickers MH, Gluckman PD, Coveny AH, Hofman PL, Cutfield WS, Gertler A, Breier BH, Harris M. The Effect of Neonatal Leptin Treatment on Postnatal Weight Gain in Male Rats Is Dependent on Maternal Nutritional Status during Pregnancy.  Endocrinology. 2008;  149 1906-1913
• 14 Stocker CJ, Wargent E, O’Dowd J, Cornick C, Speakman JR, Arch JR, Cawthorne MA. Prevention of diet-induced obesity and impaired glucose tolerance in rats following administration of leptin to their mothers.  Am J Physiol Regul Integr Comp Physiol. 2007;  295 1810-1818
• 15 Toste FP, de Moura EG, Lisboa PC, Fagundes AT, de Oliveira E, Passos MC. Neonatal leptin treatment programmes leptin hypothalamic resistance and intermediary metabolic parameters in adult rats.  Br J Nutr. 2006;  95 830-837
• 16 Passos MC, Toste FP, Dutra SC, Trotta PA, Toste FP, Lisboa PC, de Moura EG. Role of neonatal hyperleptinaemia on serum adiponectin and suppressor of cytokine signalling-3 expression in young rats.  Br J Nutr. 2009;  101 250-256
• 17 Pereira-Toste F, Toste FP, Oliveira E, Trotta PA, Lisboa PC, de Moura EG, Passos MC. Early maternal hyperleptinemia programs adipogenic phenotype in rats.  Horm Metab Res. 2009;  41 874-879
• 18 Trevenzoli IH, Rodrigues AL, Oliveira E, Thole AA, Carvalho L, Figueiredo MS, Toste FP, Neto JF, Passos MC, Lisboa PC, Moura EG. Leptin treatment during lactation programs leptin synthesis, intermediate metabolism, and liver microsteatosis in adult rats.  Horm Metab Res. 2010;  42 483-490
• 19 Trevenzoli IH, Valle MMR, Machado FB, Garcia RM, Passos MC, Lisboa PC, Moura EG. Neonatal hyperleptinemia programmes adrenal medullary function in adult rats: effects on cardiovascular parameters.  J Physiol. 2007;  580 629-637
• 20 Trevenzoli IH, Pinheiro CR, Conceição EP, Oliveira E, Passos MC, Lisboa PC, Moura EG. Programming of rat adrenal medulla by neonatal hyperleptinemia: adrenal morphology, catecholamine secretion, and leptin signaling pathway.  Am J Physiol Endocrinol Metab. 2010;  298 E941-E949
• 21 Toste FP, Alves SB, Dutra SC, Bonomo IT, Lisboa PC, Moura EG, Passos MC. Temporal evaluation of the thyroid function of rats programmed by leptin treatment on the neonatal period.  Horm Metab Res. 2006;  38 827-831
• 22 Solomon G, Niv-Spector L, Gussakovsky EE, Gertler A. Large-scale preparation of biologically active mouse and rat leptins and their L39A/D40A/F41A muteins which act as potent antagonists.  Protein Expr Purif. 2006;  47 128-136
• 23 Rajapurohitam V, Javadov S, Purdham DM, Kirshenbaum LA, Karmazyn M. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.  J Mol Cell Cardiol. 2006;  41 265-274
• 24 Zhang J, Matheny MK, Tümer N, Mitchell MK, Scarpace PJ. Leptin antagonist reveals that the normalization of caloric intake and the thermic effect of food after high-fat feeding are leptin dependent.  Am J Physiol Regul Integr Comp Physiol. 2007;  292 868-874
• 25 Attig L, Solomon G, Ferezou J, Abdennebi-Najar L, Taouis M, Gertler A, Djiane J. Early postnatal leptin blockage leads to a long-term leptin resistance and susceptibility to diet-induced obesity in rats.  Int J Obes. 2008;  32 1-8
• 26 Blander G, Guarente L. The Sir2 family of protein deacetylases.  Annu Rev Biochem. 2004;  73 417-435
• 27 Guarente L. Sirtuins as potential targets for metabolic syndrome.  Nature. 2006;  14 868-874
• 28 Banks AS, Kon N, Knight C, Matsumoto M, Gutierrez-Juarez R, Rossetti L, Gu W, Accili D. SirT1 gain of function increases energy efficiency and prevents diabetes in mice.  Cell Metab. 2008;  8 333-341
• 29 Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschöp MH. Sirt1 protects against high-fat diet-induced metabolic damage.  Proc Natl Acad Sci USA. 2008;  105 9793-9798
• 30 Marques RG, Morales MM, Petroianu A. Brazilian law for scientific use of animals.  Acta Cir Bras. 2009;  24 69-74
• 31 Fishbeck KL, Rasmussen KM. Effect of repeated reproductive cycles on maternal nutritional status, lactational performance and litter growth in ad libitum-fed and chronically food-restricted rats.  J Nutr. 1987;  117 1967-1975
• 32 Konstantinides S, Schäfer K, Neels JG, Dellas C, Loskutoff DJ. Inhibition of Endogenous Leptin Protects Mice From Arterial and Venous Thrombosis.  Arterioscler Thromb Vasc Biol. 2004;  24 2196-2220
• 33 Fagundes AT, Moura EG, Passos MC, Santos-Silva AP, de Oliveira E, Trevenzoli IH, Casimiro-Lopes G, Nogueira-Neto JF, Lisboa PC. Temporal evaluation of body composition, glucose homeostasis and lipid profile of male rats programmed by maternal protein restriction during lactation.  Horm Metab Res. 2009;  41 866-873
• 34 Troina AA, Figueiredo MS, Moura EG, Boaventura GT, Soares LL, Cardozo LF, Oliveira E, Lisboa PC, Passos MA, Passos MC. Maternal flaxseed diet during lactation alters milk composition and programs the offspring body composition, lipid profile and sexual function.  Food Chem Toxicol. 2009;  48 697-703
• 35 Almeida NA, Cordeiro A, Machado DS, Souza LL, Ortiga-Carvalho TM, Campos-de-Carvalho AC, Wondisford FE, Pazos-Moura CC. Connexin40 messenger ribonucleic acid is positively regulated by thyroid hormone (TH) acting in cardiac atria via the TH receptor.  Endocrinology. 2009;  150 546-554
• 36 Bouret SG, Draper SJ, Simerly RB. Trophic action of leptin on hypothalamic neurons that regulate feeding.  Science. 2004;  304 108-110
• 37 Pinto S, Roseberry AG, Liu H, Diano S, Shanabrough M, Cai X, Friedman JM, Horvath TL. Rapid rewiring of arcuate nucleus feeding circuits by leptin.  Science. 2004;  304 110-115
• 38 Davidowa H, Plagemann A. Decreased inhibition by leptin of hypothalamic arcuate neurons in neonatally overfed young rats.  Neuroreport. 2000;  11 2795-2798
• 39 Passos MC, Vicente LL, Lisboa PC, de Moura EG. Absence of anorectic effect to acute peripheral leptin treatment in adult rats whose mothers were malnourished during lactation.  Horm Metab Res. 2004;  36 625-629
• 40 Bonomo IT, Lisboa PC, Pereira AR, Passos MC, de Moura EG. Prolactin inhibition in dams during lactation programs for overweight and leptin resistance in adult offspring.  J Endocrinol. 2007;  192 339-344
• 41 Dunn SL, Björnholm M, Bates SH, Chen Z, Seifert M, Myers Jr MG. Feedback inhibition of leptin receptor/Jak2 signaling via Tyr1138 of the leptin receptor and suppressor of cytokine signaling 3.  Mol Endocrinol. 2005;  19 925-938
• 42 Peppard JV, Orlans E. The biological half-lives of four rat immunoglobulin isotypes.  Immunology. 1980;  40 683-686
• 43 Israel D, Chua Jr S. Leptin receptor modulation of adiposity and fertility.  Trends Endocrinol Metab. 2010;  21 10-16
• 44 Despres JP, Marette A. Relation of components of insulin resistance syndrome to coronary disease risk.  Curr Opin Lipidol. 1994;  5 274-289
• 45 Cannon CP. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.  Am J Cardiol. 2008;  22 5-9
• 46 Guarente L, Picard F. Calorie restriction – the SIR2 connection.  Cell. 2005;  25 473-482
• 47 Feige JN, Lagouge M, Canto C, Strehle A, Houten SM, Milne JC, Lambert PD, Mataki C, Elliott PJ, Auwerx J. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation.  Cell Metab. 2008;  8 347-358
• 48 Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins.  Nature. 2009;  30 587-591
• 49 Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, Li X. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.  Cell Metab. 2009;  9 327-338
• 50 Liang F, Kume S, Koya D. SIRT1 and insulin resistance.  Nat Rev Endocrinol. 2009;  5 367-373
• 51 Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.  Nature. 2005;  434 113-118

Correspondence